M. Tatar Et Al. , "ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY," VALUE IN HEALTH , vol.19, no.7, 2016
Tatar, M. Et Al. 2016. ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY. VALUE IN HEALTH , vol.19, no.7 .
Tatar, M., Tuna, E., Senturk, A., Sarioz, F., & Konya, A., (2016). ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY. VALUE IN HEALTH , vol.19, no.7.
Tatar, MEHTAP Et Al. "ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY," VALUE IN HEALTH , vol.19, no.7, 2016
Tatar, MEHTAP Et Al. "ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY." VALUE IN HEALTH , vol.19, no.7, 2016
Tatar, M. Et Al. (2016) . "ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY." VALUE IN HEALTH , vol.19, no.7.
@article{article, author={MEHTAP TATAR Et Al. }, title={ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY}, journal={VALUE IN HEALTH}, year=2016}